279 related articles for article (PubMed ID: 17019969)
1. Analysis of TGF-beta protein expression in aggressive fibromatosis (desmoid tumor).
Ferenc T; Stalińska L; Turant M; Sygut J; Tosik D; Dziki A; Kulig A
Pol J Pathol; 2006; 57(2):77-81. PubMed ID: 17019969
[TBL] [Abstract][Full Text] [Related]
2. Analysis of APC, alpha-, beta-catenins, and N-cadherin protein expression in aggressive fibromatosis (desmoid tumor).
Ferenc T; Wroński JW; Kopczyński J; Kulig A; Sidor M; Stalińska L; Dziki A; Sygut J
Pathol Res Pract; 2009; 205(5):311-24. PubMed ID: 19124205
[TBL] [Abstract][Full Text] [Related]
3. Aggressive fibromatosis (desmoid tumors): definition, occurrence, pathology, diagnostic problems, clinical behavior, genetic background.
Ferenc T; Sygut J; Kopczyński J; Mayer M; Latos-Bieleńska A; Dziki A; Kulig A
Pol J Pathol; 2006; 57(1):5-15. PubMed ID: 16739877
[TBL] [Abstract][Full Text] [Related]
4. Analysis of p27KIP1 protein and Ki-67 expression in aggressive fibromatosis (desmoid tumor).
Ferenc T; Sygut J; Tosik D; Kopczyński J; Sidor M; Góźdź S; Kulig A; Dziki A; Turant M; Stalińska L
Pol J Pathol; 2006; 57(4):187-91. PubMed ID: 17285761
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in desmoid-type fibromatosis: a clinicopathological and immunohistochemical analysis of 46 cases.
Huang PW; Tzen CY
Pathology; 2010 Feb; 42(2):147-50. PubMed ID: 20085516
[TBL] [Abstract][Full Text] [Related]
6. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
[TBL] [Abstract][Full Text] [Related]
7. IFN-{beta} signaling positively regulates tumorigenesis in aggressive fibromatosis, potentially by modulating mesenchymal progenitors.
Tjandra SS; Hsu C; Goh YI; Gurung A; Poon R; Nadesan P; Alman BA
Cancer Res; 2007 Aug; 67(15):7124-31. PubMed ID: 17671179
[TBL] [Abstract][Full Text] [Related]
8. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
[TBL] [Abstract][Full Text] [Related]
9. Cytokines associated with the pathophysiology of aggressive fibromatosis.
Mills BG; Frausto A; Brien E
J Orthop Res; 2000 Jul; 18(4):655-62. PubMed ID: 11052503
[TBL] [Abstract][Full Text] [Related]
10. TGF-β and CTGF are Mitogenic Output Mediators of Wnt/β-Catenin Signaling in Desmoid Fibromatosis.
Varghese S; Braggio DA; Gillespie J; Toland AE; Pollock R; Mayerson J; Scharschmidt T; Iwenofu OH
Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):559-565. PubMed ID: 26894649
[TBL] [Abstract][Full Text] [Related]
11. Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor).
Tolg C; Poon R; Fodde R; Turley EA; Alman BA
Oncogene; 2003 Oct; 22(44):6873-82. PubMed ID: 14534534
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathologic and genetic studies of desmoid-type fibromatosis].
Yang JL; Wang J; Zhou XY; Li XQ; Hou YY; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2006 Mar; 35(3):145-50. PubMed ID: 16630502
[TBL] [Abstract][Full Text] [Related]
13. The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors).
Lips DJ; Barker N; Clevers H; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):3-10. PubMed ID: 18722078
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor-beta expression in extraabdominal fibromatoses: an analysis of 40 cases.
Deyrup AT; Tretiakova M; Montag AG
Cancer; 2006 Jan; 106(1):208-13. PubMed ID: 16333857
[TBL] [Abstract][Full Text] [Related]
15. Extra-abdominal aggressive fibromatosis after treatment of a Morbus Hodgkin. A case report.
Günther T; Buhtz P; Forgbert K; Freigang B; Franke A; Roessner A
Gen Diagn Pathol; 1995 Oct; 141(2):161-6. PubMed ID: 8548597
[TBL] [Abstract][Full Text] [Related]
16. Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts.
Stabellini G; Balducci C; Lilli C; Marinucci L; Becchetti E; Carinci F; Calastrini C; Dolci C; Lumare E; Locci P
Biomed Pharmacother; 2008 Sep; 62(7):436-42. PubMed ID: 18155395
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature.
Carlson JW; Fletcher CD
Histopathology; 2007 Oct; 51(4):509-14. PubMed ID: 17711447
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis.
Signoroni S; Frattini M; Negri T; Pastore E; Tamborini E; Casieri P; Orsenigo M; Da Riva L; Radice P; Sala P; Gronchi A; Bertario L; Pierotti MA; Pilotti S
Clin Cancer Res; 2007 Sep; 13(17):5034-40. PubMed ID: 17785554
[TBL] [Abstract][Full Text] [Related]
19. [Extra-abdominal desmoid tumor. Microscopic aspects and histogenesis].
Salloum H; Kanitakis J; Chouvet B; Grimand P; Claudy A
Ann Dermatol Venereol; 1993; 120(10):685-8. PubMed ID: 8161098
[TBL] [Abstract][Full Text] [Related]
20. [Abdominal desmoid tumor: pathologic and therapeutic concepts].
Kourda N; Ben Slama S; Mrabet N; Sayari S; Zouache A; Ben Jilani SB; Zermani R
Tunis Med; 2008 Oct; 86(10):916-20. PubMed ID: 19472812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
